InvestorsHub Logo
Followers 31
Posts 1761
Boards Moderated 0
Alias Born 03/03/2014

Re: frosr6 post# 73929

Friday, 08/18/2017 11:29:05 AM

Friday, August 18, 2017 11:29:05 AM

Post# of 144813
PMCB is patenting the use of CIAB with the cancer fighting drugs. Did you read the article I posted 5 times to refute each of your claims?


The patent application specifically includes methods of treating all cancerous tumors, such as pancreas, liver, breast and colon, using the live-cell encapsulation of genetically modified human cells that overexpress a form of the Cytochrome P450 enzyme system normally found in the liver. These cells are encapsulated using the Cell-in-a-Box® technology. Together with low doses of ifosfamide, the encapsulated cells comprise PharmaCyte’s therapy for cancerous tumors. The patent application also includes using PharmaCyte’s platform technology with cyclophosphamide, another chemotherapy drug that must be activated by the Cytochrome P450 enzyme system.




http://pharmacyte.com/pharmacyte-biotech-strengthens-protection-of-cancer-therapy-with-patent-filing/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News